Director · Maze Therapeutics, Inc. (MAZE)

Charles Homcy, M.D director compensation at Maze Therapeutics: $602K

Fiscal year 2025 director compensation for Charles Homcy, M.D at Maze Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 28, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Charles Homcy, M.D’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Charles Homcy, M.D and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Maze Therapeutics Director Compensation Table · the one fiscal year held
In US dollars, as Maze Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$67,158—$294,907$240,000$602,065

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Maze Therapeutics, Inc. DEF 14A filed April 28, 2026, accession 0001140361-26-017463, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Maze Therapeutics, Inc. filed document, accession 0001140361-26-017463. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2026.

Get the Maze Therapeutics Board Governance Report

$602,065 Charles Homcy, M.D, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 28, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Maze Therapeutics pays directors a $40,000 cash retainer and $750,000 in Options.

Committees

FY2025 · as the proxy prints them

Nominating/Governance · Research and Development

The rest of the Maze Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Catherine Angell Sohn, Pharm.DIndependent Director$343,657
Daniel SpiegelmanIndependent Director$348,983
Hervé HoppenotChair of the Board$738,726
Jason Coloma, Ph.DDirector—
Jeffrey TongIndependent Director$0
Jonathan Lim, M.DIndependent Director$344,240
Nancy C. Andrews, M.D., Ph.DIndependent Director$345,490
Neil ExterIndependent Director$488,674
Neil Kumar, Ph.DIndependent Director$0
Richard Scheller, Ph.DIndependent Director$405,907
Sekar KathiresanIndependent Director$364,678

The full Maze Therapeutics compensation record

free company brief

This page is one director within Maze Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Order MAZE

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report